Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Urban

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Gut|January 10, 2019
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral loadAnita Schuch, Elahe Salimi Alizei, Kathrin Heim, et al.
JHEP Reports : Innovation in Hepatology|November 6, 2023
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDVRoberto Mateo, Simin Xu, Alex Shornikov, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 23, 2026
A new hepatitis delta virus hotspot in Ethiopia: a multicenter studyTeklu Shiferaw Simbo, Franziska Schlund, Frédéric Le Gal, et al.
American Journal of Human Genetics|May 15, 2024
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variationZhi Ming Xu, Gnimah Eva Gnouamozi, Sina Rüeger, et al.
Journal of Hepatology|April 29, 2023
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis deltaJulius Hollnberger, Yang Liu, Simin Xu, et al.
Nature Communications|April 5, 2020
Stem cell-derived polarized hepatocytesViet Loan Dao Thi, Xianfang Wu, Rachel L Belote, et al.
Nucleic Acids Research|June 28, 2023
CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteinsMengqian Chen, Jing Li, Li Zhang, et al.
Science Advances|April 12, 2023
An RNA-based system to study hepatitis B virus replication and evaluate antiviralsYingpu Yu, William M Schneider, Maximilian A Kass, et al.
Frontiers in Immunology|February 11, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon responseTeng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology|May 7, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon responseTeng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Gut|January 10, 2019
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral loadAnita Schuch, Elahe Salimi Alizei, Kathrin Heim, et al.
JHEP Reports : Innovation in Hepatology|November 6, 2023
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDVRoberto Mateo, Simin Xu, Alex Shornikov, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 23, 2026
A new hepatitis delta virus hotspot in Ethiopia: a multicenter studyTeklu Shiferaw Simbo, Franziska Schlund, Frédéric Le Gal, et al.
American Journal of Human Genetics|May 15, 2024
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variationZhi Ming Xu, Gnimah Eva Gnouamozi, Sina Rüeger, et al.
Journal of Hepatology|April 29, 2023
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis deltaJulius Hollnberger, Yang Liu, Simin Xu, et al.
Nature Communications|April 5, 2020
Stem cell-derived polarized hepatocytesViet Loan Dao Thi, Xianfang Wu, Rachel L Belote, et al.
Nucleic Acids Research|June 28, 2023
CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteinsMengqian Chen, Jing Li, Li Zhang, et al.
Science Advances|April 12, 2023
An RNA-based system to study hepatitis B virus replication and evaluate antiviralsYingpu Yu, William M Schneider, Maximilian A Kass, et al.
Frontiers in Immunology|February 11, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon responseTeng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology|May 7, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon responseTeng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Pageof 14